DIAMOND-BLACKFAN ANEMIA

Clinical trials for DIAMOND-BLACKFAN ANEMIA explained in plain language.

Never miss a new study

Get alerted when new DIAMOND-BLACKFAN ANEMIA trials appear

Sign up with your email to follow new studies for DIAMOND-BLACKFAN ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 2 Completed 2

New hope for rare anemias: drug may cut transfusions

Disease control Not yet recruiting

This Phase 2 trial tests the drug luspatercept (Reblozyl) in 45 people with rare inherited anemias that affect red blood cells. The goal is to see if it can reduce the need for blood transfusions in those who depend on them, or raise hemoglobin levels in those who don't. Particip…

Matched conditions: DIAMOND-BLACKFAN ANEMIA

Phase: PHASE2 • Sponsor: EuroBloodNet Association • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC

DIAMOND-BLACKFAN ANEMIA

Get alerted when new DIAMOND-BLACKFAN ANEMIA trials appear

New hope for rare anemias: drug may cut transfusions